Stocktoria

Sanara MedTech Inc. SMTI

Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Chart by TradingView
4/9
Piotroski F — financial health
-1.26
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials (annual, from 10-K)

FYRevenueNet incomeGross profitFree cash flowEquity
2025$103.1M-$37.6M$95.6M$2.2M$5.9M
2024$86.7M-$9.7M$78.5M-$229,632$38.9M
2023$65.0M-$4.3M$57.1M-$3.5M$44.6M
2022$45.8M-$7.9M$39.5M-$5.7M$41.7M
2021$24.1M-$7.9M$21.8M-$5.0M$30.2M
2020$15.6M-$4.4M$14.0M-$4.6M$5.8M

Recent insider activity (Form 4)

InsiderRoleDateActionSharesPrice
Salamone Ann Bealdirector2026-06-04Grant4,154
Ortwein Sara Ndirector2026-06-04Grant4,616
Mack Roszell IIIdirector2026-06-04Grant5,308
TANZBERGER ERIC Ddirector2026-06-04Grant5,308
Nixon Ronald Tdirector2026-06-04Grant4,154
DeSutter Robert Andrewdirector2026-06-04Grant5,539
Major Eric Ddirector2026-06-04Grant4,846
Myers Keith Gdirector2026-06-04Grant4,385

Why these scores methodology →

Piotroski F-score: 4/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -1.26 (distress)

  • Working capital / assets 0.204
  • Retained earnings / assets -1.032
  • EBIT / assets 0.1
  • Equity / liabilities 0.089

Source: SEC EDGAR filings · CIK 0000714256 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.